INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast

26 4月 2023 08:00:43 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference

11 4月 2023 08:00:35 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features

28 3月 2023 07:00:12 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

01 3月 2023 07:30:35 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

14 2月 2023 08:00:33 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

08 2月 2023 08:00:59 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1月 2023 08:00:24 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting

08 12月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

10 11月 2022 08:00:03 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast

27 10月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 8月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast

02 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

13 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

10 5月 2022 07:30:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

03 5月 2022 08:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

25 4月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors

21 4月 2022 08:00:02 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

05 4月 2022 08:00:03 条件 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

01 3月 2022 07:30:00 条件 Nasdaq GlobeNewswire